Show simple item record

dc.contributor.authorWallace, Aaron
dc.contributor.authorWest, Kim
dc.contributor.authorRothman, Alan L.
dc.contributor.authorEnnis, Francis A.
dc.contributor.authorLu, Shan
dc.contributor.authorWang, Shixia
dc.date2022-08-11T08:08:33.000
dc.date.accessioned2022-08-23T15:58:45Z
dc.date.available2022-08-23T15:58:45Z
dc.date.issued2013-10-01
dc.date.submitted2015-10-08
dc.identifier.citationHum Vaccin Immunother. 2013 Oct;9(10):2095-102. doi: 10.4161/hv.26009. Epub 2013 Aug 13. <a href="http://dx.doi.org/10.4161/hv.26009">Link to article on publisher's site</a>
dc.identifier.issn2164-5515 (Linking)
dc.identifier.doi10.4161/hv.26009
dc.identifier.pmid23941868
dc.identifier.urihttp://hdl.handle.net/20.500.14038/30508
dc.description.abstractIn the current study, immune responses induced by Gag DNA vaccines with different designs were evaluated in Balb/C mice. The results demonstrated that the DNA vaccine with the full length wild type gag gene (Wt-Gag) mainly produced Gag antigens intracellularly and induced a higher level of cell-mediated immune (CMI) responses, as measured by IFN-gamma ELISPOT, intracellular cytokine staining (ICS), and cytotoxic T lymphocytes (CTL) assays against a dominant CD8(+) T cell epitope (AMQMLKETI). In contrast, the addition of a tissue plasminogen activator (tPA) leader sequence significantly improved overall Gag protein expression/secretion and Gag-specific antibody responses; however, Gag-specific CMI responses were decreased. The mutation of zinc-finger motif changed Gag protein expression patterns and reduced the ability to generate both CMI and antibody responses against Gag. These findings indicate that the structure and post-translational processing of antigens expressed by DNA vaccines play a critical role in eliciting optimal antibody or CMI responses.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=23941868&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906393/
dc.subjectAnimals
dc.subjectCytotoxicity Tests, Immunologic
dc.subjectEnzyme-Linked Immunospot Assay
dc.subjectFemale
dc.subjectHIV-1
dc.subjectInterferon-gamma
dc.subjectMice
dc.subjectMice, Inbred BALB C
dc.subjectProtein Transport
dc.subjectT-Lymphocytes
dc.subjectVaccines, DNA
dc.subjectgag Gene Products, Human Immunodeficiency Virus
dc.subjectBiological Factors
dc.subjectGenetics and Genomics
dc.subjectImmunology and Infectious Disease
dc.subjectImmunology of Infectious Disease
dc.subjectImmunoprophylaxis and Therapy
dc.titlePost-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1)
dc.typeJournal Article
dc.source.journaltitleHuman vaccines and immunotherapeutics
dc.source.volume9
dc.source.issue10
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/faculty_pubs/786
dc.identifier.contextkey7693437
html.description.abstract<p>In the current study, immune responses induced by Gag DNA vaccines with different designs were evaluated in Balb/C mice. The results demonstrated that the DNA vaccine with the full length wild type gag gene (Wt-Gag) mainly produced Gag antigens intracellularly and induced a higher level of cell-mediated immune (CMI) responses, as measured by IFN-gamma ELISPOT, intracellular cytokine staining (ICS), and cytotoxic T lymphocytes (CTL) assays against a dominant CD8(+) T cell epitope (AMQMLKETI). In contrast, the addition of a tissue plasminogen activator (tPA) leader sequence significantly improved overall Gag protein expression/secretion and Gag-specific antibody responses; however, Gag-specific CMI responses were decreased. The mutation of zinc-finger motif changed Gag protein expression patterns and reduced the ability to generate both CMI and antibody responses against Gag. These findings indicate that the structure and post-translational processing of antigens expressed by DNA vaccines play a critical role in eliciting optimal antibody or CMI responses.</p>
dc.identifier.submissionpathfaculty_pubs/786
dc.contributor.departmentCenter for Infectious Diseases and Vaccine Research
dc.contributor.departmentDepartment of Medicine, Division of Infectious Diseases and Immunology
dc.contributor.departmentLaboratory of Nucleic Acid Vaccines
dc.source.pages2095-102


This item appears in the following Collection(s)

Show simple item record